In this study, we explored the anti-fibrosis effect of Rb in TGF-β1-stimulated A549 cells and in a bleomycin-induced rat model to provide basic data for the development of therapeutic agents through the significant inhibition of IPF. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.